Status: current, Defined. Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3689702014 | Galactose 2.49 g and palmitic acid 2.5 mg powder for suspension for injection vial | en | Synonym | Active | Case insensitive | SNOMED CT core |
| 3689703016 | Product containing precisely galactose 2.49 gram and palmitic acid 2.5 milligram/1 vial powder for conventional release suspension for injection (clinical drug) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Galactose 2.49 g and palmitic acid 2.5 mg powder for suspension for injection vial | Is a | Galactose and palmitic acid only product in parenteral dose form | true | Inferred relationship | Some | ||
| Galactose 2.49 g and palmitic acid 2.5 mg powder for suspension for injection vial | Is a | Product manufactured as parenteral dose form | false | Inferred relationship | Some | ||
| Galactose 2.49 g and palmitic acid 2.5 mg powder for suspension for injection vial | Has manufactured dose form | Powder for suspension for injection | true | Inferred relationship | Some | ||
| Galactose 2.49 g and palmitic acid 2.5 mg powder for suspension for injection vial | Has presentation strength denominator unit | Vial | true | Inferred relationship | Some | 2 | |
| Galactose 2.49 g and palmitic acid 2.5 mg powder for suspension for injection vial | Is a | Galactose- and palmitic acid-containing product | false | Inferred relationship | Some | ||
| Galactose 2.49 g and palmitic acid 2.5 mg powder for suspension for injection vial | Has presentation strength denominator value | 1 | false | Inferred relationship | Some | 2 | |
| Galactose 2.49 g and palmitic acid 2.5 mg powder for suspension for injection vial | Has presentation strength denominator value | 1 | false | Inferred relationship | Some | 1 | |
| Galactose 2.49 g and palmitic acid 2.5 mg powder for suspension for injection vial | Has unit of presentation | Vial | true | Inferred relationship | Some | ||
| Galactose 2.49 g and palmitic acid 2.5 mg powder for suspension for injection vial | Count of base of active ingredient | 2 | false | Inferred relationship | Some | ||
| Galactose 2.49 g and palmitic acid 2.5 mg powder for suspension for injection vial | Has presentation strength denominator unit | Vial | true | Inferred relationship | Some | 1 | |
| Galactose 2.49 g and palmitic acid 2.5 mg powder for suspension for injection vial | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 2 | |
| Galactose 2.49 g and palmitic acid 2.5 mg powder for suspension for injection vial | Has presentation strength numerator unit | g | true | Inferred relationship | Some | 1 | |
| Galactose 2.49 g and palmitic acid 2.5 mg powder for suspension for injection vial | Has BoSS | Palmitic acid | true | Inferred relationship | Some | 2 | |
| Galactose 2.49 g and palmitic acid 2.5 mg powder for suspension for injection vial | Has precise active ingredient | Palmitic acid | true | Inferred relationship | Some | 2 | |
| Galactose 2.49 g and palmitic acid 2.5 mg powder for suspension for injection vial | Has BoSS | Galactose | true | Inferred relationship | Some | 1 | |
| Galactose 2.49 g and palmitic acid 2.5 mg powder for suspension for injection vial | Has presentation strength numerator value | 2.5 | false | Inferred relationship | Some | 2 | |
| Galactose 2.49 g and palmitic acid 2.5 mg powder for suspension for injection vial | Has precise active ingredient | Galactose | true | Inferred relationship | Some | 1 | |
| Galactose 2.49 g and palmitic acid 2.5 mg powder for suspension for injection vial | Has presentation strength numerator value | 2.49 | false | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR